Whittier Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Buy
42,128
+7,447
+21% +$981K 0.05% 198
2026
Q1
$4.86M Sell
34,681
-89
-0.3% -$12.5K 0.05% 195
2025
Q4
$4.22M Sell
34,770
-1,693
-5% -$206K 0.05% 207
2025
Q3
$4.11M Sell
36,463
-2,578
-7% -$293K 0.05% 207
2025
Q2
$4.33M Sell
39,041
-311
-0.8% -$33.1K 0.05% 213
2025
Q1
$4.41M Sell
39,352
-421
-1% -$43.4K 0.06% 210
2024
Q4
$3.67M Sell
39,773
-745
-2% -$67.1K 0.05% 222
2024
Q3
$3.4M Sell
40,518
-2,834
-7% -$216K 0.05% 237
2024
Q2
$2.97M Sell
43,352
-1,660
-4% -$111K 0.04% 236
2024
Q1
$3.3M Sell
45,012
-2,899
-6% -$223K 0.05% 229
2023
Q4
$3.88M Sell
47,911
-3,328
-6% -$259K 0.06% 222
2023
Q3
$3.84M Sell
51,239
-634
-1% -$48.8K 0.07% 211
2023
Q2
$4M Sell
51,873
-1,000
-2% -$79.8K 0.07% 208
2023
Q1
$4.39M Sell
52,873
-4,698
-8% -$389K 0.08% 201
2022
Q4
$4.94M Sell
57,571
-10,614
-16% -$841K 0.1% 184
2022
Q3
$4.21M Sell
68,185
-5,706
-8% -$360K 0.09% 191
2022
Q2
$4.57M Sell
73,891
-13,901
-16% -$861K 0.09% 191
2022
Q1
$5.22M Sell
87,792
-75,181
-46% -$4.81M 0.09% 184
2021
Q4
$11.8M Buy
162,973
+692
+0.4% +$47.7K 0.19% 122
2021
Q3
$11.3M Buy
162,281
+2,572
+2% +$181K 0.21% 112
2021
Q2
$11M Buy
159,709
+3,434
+2% +$229K 0.2% 118
2021
Q1
$10.1M Buy
156,275
+3,471
+2% +$224K 0.2% 116
2020
Q4
$8.9M Sell
152,804
-12,652
-8% -$763K 0.19% 119
2020
Q3
$10.5M Buy
165,456
+8,200
+5% +$569K 0.25% 97
2020
Q2
$12.1M Sell
157,256
-16,536
-10% -$1.27M 0.34% 75
2020
Q1
$13M Sell
173,792
-6,768
-4% -$468K 0.42% 61
2019
Q4
$11.7M Sell
180,560
-4,503
-2% -$293K 0.31% 80
2019
Q3
$11.7M Buy
185,063
+4,710
+3% +$308K 0.34% 82
2019
Q2
$12.2M Buy
180,353
+1,132
+0.6% +$74.5K 0.36% 76
2019
Q1
$11.7M Buy
179,221
+3,940
+2% +$262K 0.36% 77
2018
Q4
$11M Sell
175,281
-4,301
-2% -$301K 0.38% 70
2018
Q3
$13.9M Buy
179,582
+2,824
+2% +$213K 0.43% 62
2018
Q2
$12.5M Sell
176,758
-2,154
-1% -$152K 0.41% 68
2018
Q1
$13.5M Buy
178,912
+10,508
+6% +$835K 0.45% 61
2017
Q4
$12.1M Sell
168,404
-1,591
-0.9% -$121K 0.42% 66
2017
Q3
$13.8M Buy
169,995
+6,459
+4% +$494K 0.5% 58
2017
Q2
$11.6M Sell
163,536
-1,277
-0.8% -$85K 0.45% 61
2017
Q1
$11.2M Buy
164,813
+7,801
+5% +$549K 0.45% 60
2016
Q4
$11.2M Buy
157,012
+9,811
+7% +$729K 0.48% 56
2016
Q3
$11.6M Buy
147,201
+8,167
+6% +$663K 0.51% 57
2016
Q2
$11.6M Buy
139,034
+251
+0.2% +$22.3K 0.51% 52
2016
Q1
$12.7M Buy
138,783
+5,977
+5% +$539K 0.56% 51
2015
Q4
$13.4M Buy
132,806
+10,838
+9% +$1.13M 0.61% 43
2015
Q3
$12M Sell
121,968
-11,573
-9% -$1.29M 0.58% 44
2015
Q2
$15.6M Sell
133,541
-4,158
-3% -$454K 0.69% 33
2015
Q1
$13.5M Sell
137,699
-9,757
-7% -$991K 0.62% 41
2014
Q4
$13.9M Sell
147,456
-4,201
-3% -$434K 0.66% 38
2014
Q3
$16.1M Buy
151,657
+497
+0.3% +$48.7K 0.79% 33
2014
Q2
$12.5M Buy
151,160
+827
+0.6% +$64.4K 0.62% 45
2014
Q1
$10.7M Sell
150,333
-2,334
-2% -$183K 0.55% 50
2013
Q4
$11.5M Sell
152,667
-18,401
-11% -$1.28M 0.59% 47
2013
Q3
$10.8M Sell
171,068
-7,713
-4% -$461K 0.58% 46
2013
Q2
$9.17M Buy
+178,781
New +$9.32M 0.51% 49

Other funds holding GILD

Whittier Trust's GILD Position: Q2 2026 in Review

Whittier Trust increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $981K and bringing the position to 42,128 shares worth $5.46M. The position accounts for 0.05% of the portfolio, ranked #198.

Whittier Trust first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.1M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Whittier Trust held 42,128 shares of Gilead Sciences worth $5.46M as of Q2 2026.
  • Whittier Trust bought 7,447 Gilead Sciences shares in Q2 2026, an estimated $981K.
  • Gilead Sciences made up 0.05% of Whittier Trust's portfolio in Q2 2026, its #198 holding.
  • Whittier Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Whittier Trust's Gilead Sciences position peaked at $16.1M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.